MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Infectious Disease, Diagnostics, Therapeutics, Pandemic Response, Vaccine Development & Vaccination
2020: Antivirals In The COVID-19 Space
Immunic, Inc. (NASDAQ: IMUX)*
Organization & Developments: Immunic
Parents
Immunic, Inc. (NASDAQ: IMUX)*
Children
2020: Biotech Analysis Central Preview Series: Immunic Therapeutics
2020: Immunic: A 'Deep Dive' On A Lottery Ticket
2021: Immunic: Competitive Phase 2 Data In Multiple Sclerosis
2022: Immunic: New MS Drugs Need Extreme Product Differentiation_seekingalpha.com
2022: Immunic: Revisiting A 'Lottery Ticket'_seekingalpha.com
2023: Immunic: Proof Of Concept With IMU-856 Provides Additional Shot On Goal_ seekingalpha.com
2023: Latest CALLIPER Data Reinforces Vidofludimus Calcium For Multiple Sclerosis
Immunic Inc. (NASDAQ: IMUX) is a small-cap biotech company developing treatments for cancer and other diseases.
Jumps
Finance & Acquisitions: Immunic
Key People: Immunic